The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to investigate drugs for treating COVID-19. The CDI will work with MSD to identify candidate treatments for the pandemic.